AVITA Medical, Inc. (RCEL): Price and Financial Metrics

AVITA Medical, Inc. (RCEL): $9.88

0.47 (-4.54%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

RCEL Price/Volume Stats

Current price $9.88 52-week high $21.70
Prev. close $10.35 52-week low $9.16
Day low $9.68 Volume 671,400
Day high $10.60 Avg. volume 197,690
50-day MA $16.41 Dividend yield N/A
200-day MA $14.84 Market Cap 253.99M

RCEL Stock Price Chart Interactive Chart >


AVITA Medical, Inc. (RCEL) Company Bio


AVITA Medical, Inc. operates as a medicine company. The Company focuses on the development and commercialization of therapies to address unmet medical needs in patients with burns, chronic wounds, and aesthetics indications. AVITA Medical serves customers worldwide.


RCEL Latest News Stream


Event/Time News Detail
Loading, please wait...

RCEL Latest Social Stream


Loading social stream, please wait...

View Full RCEL Social Stream

Latest RCEL News From Around the Web

Below are the latest news stories about AVITA MEDICAL INC that investors may wish to consider to help them evaluate RCEL as an investment opportunity.

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on December 5, 2023, at 2:00 p.m. (PS

Yahoo | December 4, 2023

AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference

VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that Jim Corbett, Chief Executive Officer, will present at the Piper Sandler 35th Annual Healthcare Conference in New York on Tuesday, November 28, 2023, at 1:00 p.m. Eastern Time. A live webcast of the present

Yahoo | November 21, 2023

AVITA Medical Updates Full Year 2023 Guidance

VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced an update to its full year 2023 guidance. This update is a result of slower-than-anticipated progression through the customer’s Value Analysis Committee (VAC) processes, driven by the expanded label application

Yahoo | November 20, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're closing out the trading week with a breakdown of the biggest pre-market stock movers worth watching for Friday morning!

William White on InvestorPlace | November 10, 2023

AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2023 Earnings Call Transcript

AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2023 Earnings Call Transcript November 9, 2023 AVITA Medical, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.53. Operator: Good day, and thank you for standing by. Welcome to the AVITA Medical Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. After […]

Yahoo | November 10, 2023

Read More 'RCEL' Stories Here

RCEL Price Returns

1-mo -39.87%
3-mo N/A
6-mo -6.97%
1-year -37.23%
3-year -53.42%
5-year -63.81%
YTD -27.99%
2023 107.88%
2022 -44.91%
2021 -35.52%
2020 -59.16%
2019 712.50%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!